English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 27 July 2020, 17:26 HKT/SGT
Share:
Singamas Advances Development of Custom-made Specialised Containers
Mobile PCR Lab Specially Developed for COVID-19 Testing
Delivered to Shanghai Pudong Airport for Arrival Testing

HONG KONG, July 27, 2020 - (ACN Newswire) - World-leading container manufacturer and logistics services provider Singamas Container Holdings Limited ("Singamas" / the "Group") (stock code: 716) has announced today that it has delivered a mobile Polymerase Chain Reaction ("PCR") laboratory for COVID-19 testing to the Shanghai Pudong Airport on 8 July 2020. The mobile laboratory can handle a maximum of 1,500 specimens a day. It consists of three functional rooms including the reagent preparation room, specimen processing room and PCR test room. Arrival testing will be commenced this week.


The mobile PCR laboratory has been developed by the Group's in-house R&D team located in Shanghai, the PRC, together with experts from the renowned Chinese Academy of Sciences and China Customs. Engineers from the Group's R&D team are dedicated to the research and development of advanced customised specialised containers meeting the needs of society as well as the demands from customers around the world. Apart from specialised transportation-focused containers, the Group's R&D team has been developing containers for use in a wide range of areas including but not limited to power generation, energy storage, data centres, housing and hotel, pressurized ex-proof, breeding and farming, as well as for scientific and medical applications.

Mr. Teo Siong Seng, Chairman of Singamas, said: "We are very excited about the development of the mobile PCR laboratory for the Shanghai Pudong Airport, and would like to thank the local government for entrusting us with this important responsibility for the city. As Singamas' specialised containers business develops, we are fascinated that when combined with modern technology, our products can be developed for diverse segments with diverse needs. With the support of our dedicated R&D team, superb manufacturing skills, and the trust and confidence of our customers, we have already developed over 1,000 types of specialised products to date. Moving forward, we are well-equipped to strengthen our product innovation and offer a comprehensive range of products to satisfy the specific needs of our community."

About Singamas Container Holdings Limited
Singamas is one of the world's major container manufacturers and logistics services providers. Its manufacturing business covers container factories located in Mainland China that focus on the manufacturing, R&D and sale of dry freight and specialised containers. Its logistics operations include container depots located in key locations in Mainland China and in Hong Kong, as well as a logistics company in Xiamen. Riding on its comprehensive investment strategies, the Group is consolidating its market leadership in the global container industry. For details, please visit: www.singamas.com.



Topic: Press release summary Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Singapore to Host the 24th Cyber Security Summit: Addressing Emerging Threats and AI-Driven Security  
Mar 6, 2025 10:16 HKT/SGT
Doubleview Gold Corp Announces Collaboration with Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. Qatar  
Mar 6, 2025 09:09 HKT/SGT
Register Now: analytica Vietnam's Largest Edition & Must-See Innovations!  
Mar 6, 2025 07:32 HKT/SGT
Hong Kong International Jewellery Show opens today showcasing global innovative designs  
Mar 5, 2025 23:01 HKT/SGT
Nissin Foods (Hong Kong) Charity Fund Supporting Talents in Food and Nutritional Sciences for the Third Consecutive Year  
Mar 5, 2025 23:01 HKT/SGT
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters  
Mar 5, 2025 22:58 HKT/SGT
General Atomics Introduces Quadratix Software Enterprise  
Mar 5, 2025 22:42 HKT/SGT
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open  
Mar 5, 2025 21:51 HKT/SGT
Giftify, Inc. Launches Sports Ticket & Merchandise Savings Platform as Fan Expenses Surge  
Mar 5, 2025 21:30 HKT/SGT
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program  
Mar 5, 2025 21:15 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575